Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 USD | -2.80% | -7.83% | -70.04% |
Jun. 10 | KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 | MT |
Jun. 05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.04% | 215M | |
+10.26% | 7.93B | |
+2.60% | 7.37B | |
+0.67% | 5.95B | |
-7.58% | 3.66B | |
-15.15% | 3.39B | |
-26.47% | 1.12B | |
+7.13% | 924M | |
-15.32% | 865M | |
-13.71% | 826M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024